Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
Sign Up to like & getrecommendations! Published in 2018 at "Current problems in cancer"
DOI: 10.1016/j.currproblcancer.2018.01.011
Abstract: Leiomyosarcomas (LMS) are rare tumors with poor prognosis owing to the high rate of recurrent and metastatic disease. The combination of doxorubicin (Adriamycin) plus ifosfamide and mesna (AIM) results in moderate response rates of 10%-30%.… read more here.
Keywords: doxorubicin treatment; treatment; treatment advanced; aim regimen ... See more keywords
The outcome of vincristine, dactinomycin D, ifosfamide and doxorubicin (VAIA) as first-line therapy for adult-patients with metastatic ewing sarcoma; a single-center experience.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e23501
Abstract: e23501Background: Ewing sarcoma family of tumors (ESFT) is a rare malignancy among adults. Most studies from western countries have reported improvement in outcomes following multi-agent chemothera... read more here.
Keywords: dactinomycin ifosfamide; outcome vincristine; vincristine dactinomycin; ewing sarcoma ... See more keywords